S

Sparrow Pharmaceuticals, Inc.

9 employees

Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for disorders of corticosteroid excess.

Basic info

pharmaceutical manufacturing

Biotechnology

Pharmaceutical

Cushing's syndrome

Inflammatory diseases

Biopharma

Polymyalgia rheumatica

New chemical entity

Pharmaceuticals

Giant cell arteritis

Corticosteroids

Therapeutics

Clinical trials

Drug development

Autoimmune diseases

2013

$50M

from 2 investors over 2 rounds

S

Sparrow Pharmaceuticals, Inc. raised $50M on May 18, 2021

Investors: RiverVest Venture Partners and OrbiMed Advisors